Hearts and bones: shared regulatory mechanisms in heart valve, cartilage, tendon, and bone development
- PMID: 16643886
- DOI: 10.1016/j.ydbio.2006.03.027
Hearts and bones: shared regulatory mechanisms in heart valve, cartilage, tendon, and bone development
Abstract
The mature heart valves are dynamic structures composed of highly organized cell lineages and extracellular matrices. The discrete architecture of connective tissue within valve leaflets and supporting structures allows the valve to withstand life-long functional demands and changes in hemodynamic forces and load. The dysregulation of ECM organization is a common feature of heart valve disease and can often be linked to genetic defects in matrix protein structure or developmental regulation. Recent studies have identified specific regulatory pathways that are active in the developing valve structures and also control cartilage, tendon, and bone development. This review will focus on the regulatory hierarchies that control normal and abnormal heart valve development in parallel with other connective tissue cell types.
Similar articles
-
BMP and FGF regulatory pathways in semilunar valve precursor cells.Dev Dyn. 2007 Apr;236(4):971-80. doi: 10.1002/dvdy.21097. Dev Dyn. 2007. PMID: 17326134
-
Chondrogenic differentiation of bovine synovium: bone morphogenetic proteins 2 and 7 and transforming growth factor beta1 induce the formation of different types of cartilaginous tissue.Arthritis Rheum. 2007 Jun;56(6):1869-79. doi: 10.1002/art.22701. Arthritis Rheum. 2007. PMID: 17530715
-
Sox9 is required for precursor cell expansion and extracellular matrix organization during mouse heart valve development.Dev Biol. 2007 May 1;305(1):120-32. doi: 10.1016/j.ydbio.2007.02.002. Epub 2007 Feb 7. Dev Biol. 2007. PMID: 17350610 Free PMC article.
-
Tenascin in connective tissue development and pathogenesis.Perspect Dev Neurobiol. 1994;2(1):125-32. Perspect Dev Neurobiol. 1994. PMID: 7530139 Review.
-
Pharmacotherapy: concepts of pathogenesis and emerging treatments. Novel targets in bone and cartilage.Best Pract Res Clin Rheumatol. 2010 Aug;24(4):489-96. doi: 10.1016/j.berh.2010.03.001. Best Pract Res Clin Rheumatol. 2010. PMID: 20732647 Review.
Cited by
-
Molecular and cellular aspects of calcific aortic valve disease.Circ Res. 2013 Jul 5;113(2):198-208. doi: 10.1161/CIRCRESAHA.113.300155. Circ Res. 2013. PMID: 23833294 Free PMC article. Review.
-
Inappropriate cathepsin K secretion promotes its enzymatic activation driving heart and valve malformation.JCI Insight. 2020 Oct 15;5(20):e133019. doi: 10.1172/jci.insight.133019. JCI Insight. 2020. PMID: 33055423 Free PMC article.
-
Toward the Effective Bioengineering of a Pathological Tissue for Cardiovascular Disease Modeling: Old Strategies and New Frontiers for Prevention, Diagnosis, and Therapy.Front Cardiovasc Med. 2021 Mar 4;7:591583. doi: 10.3389/fcvm.2020.591583. eCollection 2020. Front Cardiovasc Med. 2021. PMID: 33748193 Free PMC article. Review.
-
An autonomous BMP2 regulatory element in mesenchymal cells.J Cell Biochem. 2011 Feb;112(2):666-74. doi: 10.1002/jcb.22975. J Cell Biochem. 2011. PMID: 21268088 Free PMC article.
-
Mitral valve endothelial cells with osteogenic differentiation potential.Arterioscler Thromb Vasc Biol. 2011 Mar;31(3):598-607. doi: 10.1161/ATVBAHA.110.216184. Epub 2010 Dec 16. Arterioscler Thromb Vasc Biol. 2011. PMID: 21164078 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources